Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: B02BC

Evicel(human fibrinogen;human thrombin)

Hemostasis, Surgical

Marketing Authorisation Holder: Omrix Biopharmaceuticals N. V.

EMA Authorisation: 05/10/2008

INN: human fibrinogen;human thrombin

Indication

Evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. Evicel is also indicated as suture support for haemostasis in vascular surgery.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Evicel — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.